Results 321 to 330 of about 24,860,034 (345)

Reservoirs for HIV-1

Current Infectious Disease Reports, 1999
The success of antiretroviral therapy for HIV-1 infection has generated interest in mechanisms by which the virus can persist in the body despite the presence of drugs that effectively inhibit key steps in the virus life cycle. There are several potential cellular and anatomic reservoirs for HIV-1.
openaire   +3 more sources

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Science, 1997
Virus-specific CD4+ T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus-type 1 (HIV-1) infection.
E. Rosenberg, J. Billingsley, A. Caliendo, Steve Boswell, P. Sax, Spyros A. Kalams, B. Walker   +6 more
semanticscholar   +1 more source

A Patient with HIV-1 Superinfection

New England Journal of Medicine, 2002
An HIV-1–infected patient had a rebound in viremia when antiviral therapy was discontinued as part of a vaccine research protocol. Careful studies showed that this patient was infected initially with subtype AE of the virus but then became infected with subtype B.
Jost, Stéphanie, Bernard, Marie-Charlotte, Kaiser, Laurent, Yerly Ferrillo, Sabine, Hirschel, Bernard, Samri, Assia, Autran, Brigitte, Goh, L. E., Perrin, Luc   +8 more
openaire   +4 more sources

Mathematical Analysis of HIV-1 Dynamics in Vivo

SIAM Review, 1999
Mathematical models have proven valuable in understanding the dynamics of HIV-1 infection in vivo. By comparing these models to data obtained from patients undergoing antiretroviral drug therapy, it has been possible to determine many quantitative ...
A. Perelson, P. Nelson
semanticscholar   +1 more source

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Science, 1996
Yu Feng, C. Broder, P. Kennedy, E. Berger   +3 more
semanticscholar   +1 more source

Th1 and th2 responses, HIV-1 coreceptors, and HIV-1 infection.

Journal of biological regulators and homeostatic agents, 2001
The Th1/Th2 model provides an interesting paradigm for understanding several pathophysiological processes and possibly for developing new immunotherapeutical strategies. In HIV-1 infection the interaction between the type of HIV-1 strain and the pathway of the ongoing T-cell effector response, despite its complexity, may represent one of the crucial ...
G. GALLI, ANNUNZIATO, FRANCESCO, COSMI, LORENZO, R. MANETTI, MAGGI, ENRICO, ROMAGNANI, SERGIO   +5 more
openaire   +3 more sources

Identification of a major co-receptor for primary isolates of HIV-1

Nature, 1996
H. Deng, Rong Liu, W. Ellmeier, Sunny S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marmon, R. Sutton, C. Hill, C. Davis, S. Peiper, T. Schall, D. Littman, N. Landau   +14 more
semanticscholar   +1 more source

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Nature, 1995
D. Ho, A. Neumann, A. Perelson, Wen Chen, J. Leonard, M. Markowitz   +5 more
semanticscholar   +1 more source

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

Science, 1996
A. Perelson, A. Neumann, M. Markowitz, J. Leonard, D. Ho   +4 more
semanticscholar   +1 more source

HIV-1 and the thymus

AIDS, 1997
Glen N. Gaulton, Michael Rosenzweig, Janice V. Scobie   +2 more
openaire   +3 more sources